Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Magnesium oxide (MgO)

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 14 USDMF, 2 CEP/COS, 11 JDMF, 2 KDMF, 4 NDC API, 10 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

FINISHED DOSAGE FORMULATIONS

63 FDF Dossiers, 6 FDA Orange Book, 19 Europe, 5 Canada, 21 South Africa, 12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 9 Rochem International Inc, 19 SPI Pharma, 24 DKSH, 1 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 2 Kewpie Corporation, 9 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 7 Kirsch Pharma, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 1 Avesta Pharma, 34 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 1 Clariant, 11 Corel Pharma Chem, 4 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 13 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 10 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 41 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

96 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 52 Thickeners and Stabilizers, 45 Disintegrants & Superdisintegrants, 38 Solubilizers, 37 Taste Masking, 36 Direct Compression, 36 Parenteral, 30 Granulation, 29 Controlled & Modified Release, 26 Topical, 25 Film Formers & Plasticizers, 22 Chewable & Orodispersible Aids, 21 Lubricants & Glidants, 16 Emulsifying Agents, 15 Co-Processed Excipients, 13 Rheology Modifiers, 9 Empty Capsules, 8 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 9 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

MARKET PLACE

12 APIs, 2 FDF Dossiers, 5 EXCIPIENTS

PATENTS & EXCLUSIVITIES

6 US Patents

6 US Patents

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	ICL Industrial Products	Israel	Ace Biopharm Co., Ltd.	20210827-211-J-1007	magnesium oxide	2021-08-27	DEAD SEA BROMINE COMPANY Ltd. MAGNESIA PRODUCTS SBU	Israel	DEAD SEA PERICLASE Mishor Rotem, MP Arava, 8680600, Israel
29/11/2025	ICL Industrial Products	Israel	Farm East Co., Ltd.	20210827-211-J-1007(1)	magnesium oxide	2022-03-17	DEAD SEA BROMINE COMPANY Ltd. MAGNESIA PRODUCTS SBU	Israel	DEAD SEA PERICLASE Mishor Rotem, MP Arava, 8680600, Israel

Magnesium Oxide (MgO)

Magnesium oxide (MgO)

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers

14 USDMF

2 CEP/COS

11 JDMF

2 KDMF

4 NDC API

10 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

FINISHED DOSAGE FORMULATIONS

63 FDF Dossiers

6 FDA Orange Book

19 Europe

5 Canada

21 South Africa

12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT

RELATED EXCIPIENT COMPANIES

2 EUROAPI

9 Rochem International Inc

19 SPI Pharma

24 DKSH

1 Pharm-RX Chemical

8 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

2 Kewpie Corporation

9 Nanjing Well Pharmaceutical

2 Pfanstiehl

7 Kirsch Pharma

4 ACG Worldwide

11 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 Ashland

1 Avesta Pharma

34 BASF

1 Bioplus Life Sciences

1 CD Formulation

1 Clariant

11 Corel Pharma Chem

4 DFE Pharma

1 Esteem Industries

2 Finar

13 Gangwal Chemicals

5 Ideal Cures

5 Ingredion Pharma Solutions

13 Kerry

4 Keval Exports

5 Kima Chemical

6 Lonza Capsugel

18 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

10 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

41 Roquette

13 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

3 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 Silverline Chemicals

4 The Dow Chemical Company

2 Ulanqab Kema New Material

FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons